<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 158 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page157.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=158">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 158 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 158</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=158"><img src="../thumb/158.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents -7.5 / 7.5.1 / 7.5.2 / 7.6 / 7.7 / 7.7.1                2020-04 / 127
       (S4) TABS. A40/7.1.5/0131     Dosage: Admin.aseptic.dil.sol.as IV admixture in 0,9% NaCl/5%   Dosage: Adults: 3-6 amps dly. Childr.und. 1 yr: ½-1 amp dly. 4
       714128-001: 20 mg, 90, R5 789,83  dextr.with aid of syr.pump in hosp. und.contin.CV monit.  yrs: up to 1½ amps dly. 8 yrs: 1-2 amps.dly. 13 yrs: 1½-3 amps dly.
       Dosage: Adults: Recomm.dos: 20 mg 3xdly. Effic.not est.in suffic.  Init: 1-2 mg/hr adjust.indiv. Max.dos.not exceed. 12 mg/hr. Heart fail.  Admin.IVI, IV infus, IM, SC.
       number of pts.beyond 12 wks.treatm.  pts.may req.dos.up to 20 mg/hr.  Contraindications: Phaeochromocyt., narr.angl. glauc., thyrotox-
       Poss.dos.adjustm.with co-admin.bosentan/other CYP3A4 induc.  Contraindications: Nitrates/nitrites hypersens., low L ventric.fill.  ic., prostat.hypertrophy with urin. retent., hypertens., coron.heart
       Contraindications: Reg.or intermitt.concom. use of nitric oxide   press., hypertrophy.obstruct. cardiomyopathy, cardiogen.shock, sev.  fail., hypertroph. obstruct.cardiomyopathy, 1st trimest.pregn., lactat.
       donors/organ.nitrates or nitrites, concom.potent cytochrome P450   hypotens., mark. anaem., head trauma, cerebr.haemorrh., hypovol-  Side effects: Palpitat., tachycard., anx., sweat., insomn., naus.,
       3A4 inhibit.eg.ritonavir/erythromycin/saquinavir/ketoconazole &   aem., clos.angle glauc., dis.assoc.with incr. IC-press., constrict.pericar-  trem., press.sensat.in head, in hypersens. pts.angin.pain, card.ar-
       itraconazole, sev. hepat../ren.impairm., not recomm.in pulm.veno-  dit., card.tamponade, circulat.collapse, aortic/mitr.stenos., concom.   rhythm.& unwant. B/P incr.
       occlus.dis., inadeq.data for use in pregn., breast feed., safety & ef-  phosphodiesterase 5 inhibits.  Special precautions: Excl.heart valve/centr. arter.stenos.as cause
       fic.not demonstrat.in childr.  Side effects: Headache, light headedn.in upright posit., dizzin.,   of hypotens.1st., card. arrhythm., tachycard., sev.CV disords., safety
       Side effects: Ser.CV events mostly in pts.with pre-exist.CV risk fact.,   drowsin., reflex tachycard., sev. hypotens. poss. lead.to ang.pect.  in 2nd & 3rd trimest.of pregn.not est.
       non-arterit.anter. ischaem. optic neuropathy, headache, flush., dys-  exacerbat., hypotens. on stand., flush., collapse somet. accomp.   Drug interactions: Eff.enhanc.by guanethid., mineralocorticoids,
       peps., back/ limb pain, diarrh., cellulit., influenza, sinusit., anaem.,   by bradydysrhythm.& syncope, sympt.of cerebr. ischaem., cyanos.,   sympathomimet./subst.with sympathomimet.activ., halogen.aliphat.
       fluid retent., insomn., anx., migraine, trem., paraesthes., burn.sen-  methaemoglobinaem., cold skin, imp.resp., bradycard., hypox., N&V,   hydrocarb. may enhanc.eff.of sympathomimet.agents on the heart,
       sat., hypoaesthes., reduc.vis.acuity, retin.haemorrh., vis. disturbs.,   heartburn, allerg.skin reacts., angioed., Stev.-John. syndr., exfoliat.  effs.part./complet.abolish.by adrenerg. block. agents.
       photophob., diplop., chromatopsia., cyanopsia, abnorm.eye sensat.,   dermatit., feel.of weakn.
       eye irrit., vertigo, bronchit., epitax., rhinit., cough, GI disturbs., haem-  Warnings and special precautions: Do not use infus.mat.made   GLYPRESSIN, Ferring &
       orrh., alopec., erythema, myalg., gynaecomast., pyrex., incr. weight,   from PVC/PU as signific.loss.due to adsorpt.occur, hypothyroid., hypo-  Terlipressin
       uni-.or bilater. decr./loss of hear.with /without assoc.vestibul. sympts.  therm., malnutrit., sev.liv/ren.dis., orthostat.hypotens., use simultane-  Indications: Bleed.oesophag.varices.
       Report.S/E but not assoc.with PAH incl: dizzin., postur.hypotens./  ous.with eith.posit.inotrop.meds/assist. circulat & contin. haemody-  (S4) SOL.FOR INJ. 43/21.13/0829.
       hypotens., ang.pector., AV block, migraine, syncope, tachycard.,   nam.monit when infus. absolut.need.with init.hypotens.& low ventric.  722839-001: 0,1 mg/ml, 5x8,5 ml amps, R2 076,64
       palpitat., card. arrest, heart fail., abnorm.ECG, cardiomyopathy, ab-  fill. press., poss. toler.theref.contin.high dos.to be avoid., monit.BP &     Dosage: Init.IV inj.of 17 ml (2 amps) giv.4 hrly. Ther. to be maint.until
       norm.vis.predomin.col tinge, diplop., tempor.vis.los./decr.vis., ocul.   pulse, poss.myocard. hypox. esp.in coron.art.dis., control.Na diet,   bleed.contr.for 24 hrs.but up to max. of 48 hrs. Dos.may be adjust.to
       redn./-swell./-press.,/-burn., bloodshot appear., incr.IOP, retin.vasc.  pregn.& lactat., excret.in breast milk poss.caus. methaemoglobi-  8,5 ml (1 amp) IV 4 hrly.in pts.with bm&lt; 50 kg or in case of adverse eff.
       dis/-bleed., virtreous detachm./ -tract., paramacul.oed., conjunc-  naem.in infts., safety & effic.in childr. not est., sev.ren./hepat.impairm.  Contraindications: Sept.shock where card. output low, childr., mix.
       tivit., photophob., eye haemorrh., cataract., dry eyes, eye pain, pria-  Drug interactions: Enhanc.hypotens.eff.with phosphodiesterase   with other meds., pregn.
       pism., cystit., noctur., urine freq./ incontin., breast enlargem., abnorm.  type 5 inhibits.& poss. neurolept. & TCA’s, hypotens.eff.of meds.with   Side effects: Paleness, incr.BP, GI disturbs., headache, hyponatraem.,
       ejaculat., genit.oed., anorgasm., haematur., face oed., photosensitiv.  BP low.propert.potent., incr.bld.lev. dihydroergotamine.  card. disords.incl.MI/CF, chest pain, fluid overload with pulm.oed., pe-
       react., shock, asthen., pain, chills, accident.fall/injury, allerg.reacts.,   riph. vasoconstrict./ ischaem./cyanos., hypertens., intest. ischaem.,
       chest pain, leukopen., thirst, oed, gout, unstable diab., hyper-/hypo-  hot flush., resp.distress/fail., dyspn., skin/inj.site necros., uter.con-
       glycaem., hyperuricaem., hypernatraem., arthrit., arthros., tend.rupt.,   strict., decr. uter.blood flow.
       tenosynovit., bone pain, myasthen., synovit., CNS & nerv.syst.effs.,  7.5.2   Peripheral vasodilators  Warnings and special precautions: Monit. BP/heart rate/fluid
       nas.congest., asthma, dyspn., laryngit., pharyngit., bronchit., cough,   bal., hypertens./recogn.heart dis., contr.sod.diet, elderly, special.
       incr. sputum, skin disords., tinnit., deafn., ear pain.  DYNA PENTOXIFYLLINE SR, Pharma Dynamics [P/S]  supervis.with facilit. for CV/haemat./electrol.monit., do not use in
       Warnings and special precautions: MI/ stroke/life threaten.   Pentoxifylline  breast feed.women.
       arrhythm.with.last 6 mnths., rest.hypotens. (&lt;90/50)/hypertens.  Indications: Symptomat. relief of intermitt. claudicat.assoc.with   Drug interactions: Incr.hypotens.eff. of non-select. β-blocks. on
       (&gt;170/110), card.fail.or coron.artery dis.caus.unstable ang., retinit.   chron.occlus. arter.limb disords & trophic ulc., Raynaud syndr.  port.vein, low.heart rate/card. output with concom.meds.with a
       pigmentosa (minority have genet.retin. phosphodiesterase disor-  (S2) SR TABS, A36/8/0282  known bradycard. eff.
       ds.), underly.CV dis.poss. affect.by vasodilat.effs.esp.in combinat.  709077-001: 400 mg, 30, R263,10  See also MDR page 327.
       with sex. activ., anatomic.deform.of penis, condits. predispos. to   Dosage: 1 tab 2-3xdly aft.meals.
       priapism, ensure pts.on alpha-block. ther.are haemodynamic.stable   Contraindications: Cerebr./extens.retin. haemorrh., ac.MI, con-
       bef.init. treatm., bleed.disords., act.pept.ulcerat., epitax. incid.high.in   com.ketorolac as bld.risk incr.&/prothromb.time prolong, safety in
       pulm.arter.hypertens. second.to connect. tiss.dis.& in pts.treat.with   pregn.& lactat.not est.  7.7   Hipolipidaemic agents
       concom.oral vit K antagon., prev.non-arterit.anter. ischaem. optic   Side effects: Naus., GI disturbs., dizzin., headache, flush., ang.pect.,
       neuropathy (NAION) or NAION risk fact.  palpitat., card. arrhythm., hypersens.reacts., bleed.events in assoc.
       Drug interactions: Anti-aggregat.eff.of Na nitroprusside potent.,   with bleed.risk fact.  7.7.1  Fibrates
       clear.reduc.by inhibit of cytochrome P450 & isoforms 3A4 & 2C9 &   Special precautions: Ischaem.heart dis., hypotens., cirrhos., imp.
       induc. of these isoenzym.incr.clear., clear.reduc.with CYP3A4 sub-  ren./liv.funct., unstable circulat., pts.at risk from BP reduct.  BEZALIP, Teva [P/S]
       strates & combinat.of CYP3A4 substrates & beta-block., bosentan   Drug interactions: Eff.of antihypertens.agent potent., high par-  Bezafibrate.
       decr. sildenafil AUC & C max and sildenafil incr.AUC and C max of bosen-  enter.dos.may enhanc. hypoglycaem. act.of insul/oral antidiabet.  Indications: Prim.hyperlipidaem.type 11a, 11b, 111, 1V & V (Fre-
       tan, incr., symptomat.hypotens.in a few suscept. indiv. with alpha-  drickson class) when diet & lifestyle improvem.not adeq., second
       block.ther., potent. hypotens. eff.of nitr.  PAPAVERINE 60, (Litha) Pharmacare [P/S]  hyperlipidaem. when improvem.insuffic.aft. correct. underly.disords.
                                     Papaverine HCl.
       VOLIBRIS, GSK                 Indications: Dilat.& incr.arter./venous bld.flow by intragraft admin.  (S3) TABS, Q/7.5/104
       Ambrisentan                   dur.coron.bypass., prevent./ alleviat.of dissect./handling induc.graft   708453-007: 200 mg, 90, R610,32
       Indications: To improve exerc.capac./decr.PAH sympts & delay clinic.  spasm by perigraft admin.dur.coron.artery bypass.  Dosage: Swall.whole.1 tab.2-3xdly.aft.meals.
       worsen.in pulm.arterial hypertens.(PAH).  (S3) SOL.FOR INJ. X/7.1.5/204. 60 mg/2 ml.  (S3) RETARD TABS, S/7.5/270
       (S4) TABS, 45/7.1.3/0106, 0107  787027-006: 5x2 ml amps, R812,64  779644-018: 400 mg, 30, R243,38
       723036-001: 5 mg, 30, R6 325,00  Dosage: Admin.by slow intragraft inj if vasodilat. & incr.bld.flow   Dosage: Swall.whole.1 tab.in morn.or even.with/ aft. meals.
       723038-001: 10 mg, 30, R6 325,00  through vessel graft.desir. Max. recomm.dos: 30 mg  Contraindications: Liv.dysfunct., dialys., dialys. with imp.ren.funct.,
       Dosage: Treatm.by exper.physic.only.  Admin.by perigraft inj.to prev.vessel spasm dur. dissect. & graft handl.   nephrot.syndr., other fibrate hypersens., concom.HMG CoA reduct.
       Init.5 mg once dly. May be incr.to 10 mg once dly.if tol.  Max. recomm.dos: 30 mg.  inhibit.in pts. with myopathy predispos.facts., known photoallerg. /
       Concom.ciclospor.A: Limit dos.to 5 mg once dly,  Mix with 200 ml norm.sal.as rins.sol.to dil/prev. graft spasm from the   phototox.reacts.to fibrates, insuffic. exper.in childr., MAOI with hepa-
       Contraindications: Pregn.& lactat., sev.hepat. impairm., idiopath.  intern.mammary artery & saphen.vein.   totox.potent., pregn. & lactat., Retard Tabs: elderly.
       pulm.fibros.with/without pulm.hypertens.  Contraindications: Compl.AV heart block.  Side effects: Gallston., musc.weakn./cramps, myalg., rhabdomyolys.
       Side effects: Anaem.poss.req.transfus., hypersens., headache,   Side effects: GI disturbs., fac.flush., headache, drowsin., skin   prim.with imp.ren.funct., GI disturbs., pancytopen., thrombocytopen.,
       palpitat., flush., nas. congest., sinusit., nasopharyngit., abdom.pain,   rash, sweat., vertigo, arrhythm., tachycard., hepatit. rarely prog-  hypersens. reacts., dizzin., headache, cholelithias., cholestas., skin
       constipat., fluid retent., periph.oed., HF assoc.with fluid retent., dyspn.  ress.to cirrhos.  reacts.incl.thrombocytopen., purpura/ erythema multiforme/Stev.-
       with worsen.from unclear aetiology, N&V, incr.hepat.transamin.,   Warnings and special precautions: Glauc., do not add to lactat.   Johns.syndr. & tox.epiderm.necrolys., photosens.reacts., alopec.,
       hepat.injury, auto-immune hepatit.  Ringers inj.as precipitat.will occu, discont.in hepat.hypersens.with GI   erect.dysfunct., ac.ren.fail.
       Warnings and special precautions: Eval.hepat. funct.bef.init.&   sympts./jaund./eosinophil./alt.liv.test values, safety & effectiven.in   Special precautions: Fatty liv., gall.bladd.dis. with/ without chole-
       monit.for aminotransfer.elev. discont. if S&S of hepat.injury pres.,   childr.not est., safety in pregn.& lactat.not est.  lithias., concom.oestrog. contracept., poss.rhabdomolys.risk with
       auto-immune hepatit.& hepat.injury report., concom.meds. known to   HMG CoA reduct. inhibits.theref.admin.in except.case only & monit.
       be assoc.with hepat.injury, optimis.auto-immune hepatit.managem.  clos.for myopathy sympts., discont.combin. ther. immed.in case of
       prior & dur.ther.discont. if hepatit.S&S/exacerbat.observ., monit.Hb   myopathy, pts.receiv.with cholestyramine 2 hrs.interv betw.medic.,
       prior to init./aft.1 mnth.& period. thereaft., manage pre-exist. fluid  7.6  Vasoconstrictors  monit. bld. clott.status with concom.coumarin, imp.ren. funct. with
       overload prior to init.ther., determine cause of fluid retent.if devel-  GLYPRESSIN (MDR Listings)  concom.immuno-suppress.ther.in transpl. pts., instit.diet.meas., grad.
       ops, consid.poss. pulm. veno-occlus.dis.if ac.pulm.oed.develops, lact.   dos.incr.in gastric sensit., adjust dos.accord.to ser.creatin. lev. in ren.
                                                                                      st
       intol., teratogen.in anim.stud., excl.pregn.bef. init. ther.& practice   AKRINOR, AI Pharm Ltd  insuffic., monit.liv.funct.& triglycer.lev. 3x dur.1  8 wks.(discont.if no
       reliable contracept.methods, testic.tubul.atrophy in male anim.with   Cafedrine HCl 100 mg, theodrenaline HCl 5 mg  signif.reduct.), elderly.
       chron. admin. but eff.on human fertil.not known, not recomm. in pts.  Indications: Circulat.weakn./collapse, prim.-/second.-& orthos-  Drug interactions: Poss.incr.lipid lev.with oestrogs., cholestryramine
       und.18 yrs., hepat.impairm.   tat.hypotens.                imp.absorpt., poss. interact. with oral coumarin anticoags., act.of in-
       Drug interactions: Ciclospor.A incr.expos.  (S3) TABS, G2904  sul. & sulphonylureas poss.potent., poss.myopathy with dos.reduct.
                                     701513-004: 30, R231,72      DYNA BEZAFIBRATE 400 SR, Pharma Dynamics [P/S]
                                     Dosage: Swallow whole. Adults: 1-2 tabs.1-2xdly. Reduc.dos.aft.5-  Bezafibrate.
       7.5.1   After-load reducers   10 days. Childr.: 1 tab.in morn.  Indications: Prim.hyperlipidaem.type IIa, IIb, IV (Fredrickson class)
                                     Contraindications: Mitral stenos., glauc., beta-block.ther.
                                     Side effects: Palpit., poss.intens.angin.effs.  (S3) SR TABS, 36/7.5/0280
       ACCUPRIL, Pfizer Laboratories (Pty) Ltd  Special precautions: Ang.pts., pregn.  710122-001: 400 mg, 30, R238,71
       See Section 7.3.8             Drug interactions: Poss.major fall in heart rate with beta-block.  Dosage: Instit.diet.meas.,
                                                                  1 tab.in even.aft.meal.
       ISOKET 0,1%, GSK [P/S]        EFFORTIL, (Sanofi-Aventis) Ing.Pharm [N/P/S in C]  Contraindications: Sev.liv./kidn.dysfunct., prim. bil.cirrhos/gall-
       Isosorbide dinitrate          Etilefrine HCl.              stones or gallbladd.disords., safety in pregn.& lactat.not est., MAOI
       Indications: Sev.ang.pect., ac.myocard.infarct., ac.(L) ventric.fail.  Indications: Hypotens.in circulat.fail., dur. anaesth., post-op.  with hepatotox. potent.
       (S3) IV SOL, W/7.1.4/360. 1 mg/ml  (S2) AMPS. F/5.1/197. 10 mg/ml.  Side effects: GI disturbs., headache, dizzin., fatig., drowsin., skin
       791806-006: 10x10 ml amps, R494,67  722359-004: 5x1 ml, R194,06  rash, prurit., alopec., impot., anaem., leucopen., hepatomegaly.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page157.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page153.html">153</a>&nbsp;&nbsp;&nbsp;<a href="page154.html">154</a>&nbsp;&nbsp;&nbsp;<a href="page155.html">155</a>&nbsp;&nbsp;&nbsp;<a href="page156.html">156</a>&nbsp;&nbsp;&nbsp;<a href="page157.html">157</a>&nbsp;&nbsp;&nbsp;<a href="page158.html">158</a>&nbsp;&nbsp;&nbsp;<a href="page159.html">159</a>&nbsp;&nbsp;&nbsp;<a href="page160.html">160</a>&nbsp;&nbsp;&nbsp;<a href="page161.html">161</a>&nbsp;&nbsp;&nbsp;<a href="page162.html">162</a>&nbsp;&nbsp;&nbsp;<a href="page163.html">163</a>
             </td>
             <td width="35%"><a href="page159.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page159.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
